• Contact
• About APA
• Site Map

• Psychiatric Practice
  • Addiction Psychiatry
  • Ethics
  • Managing Your Practice
  • Medicare Medicaid
  • Practice Guidelines
  • Quality Improvement
• Education & Career Development
  • Educational Initiatives
  • Lifelong Learning & CME
  • Medical Students
  • Meetings
  • Melvin Sabshin Library & Archives
  • Residents
• Research
  • DSM
  • International Programs
  • Psychiatric Research Report
  • Health Policy Analysis
  • APIRE
  • Practice Research Network and Health Services Research
  • Research Training and Funding
  • Research in Residency
  • Research Colloquium for Junior Investigators
  • Endowment Campaign
• Advocacy
  • APA AMA Delegation
  • Communications & Public Affairs
  • Financing Health Care
  • Government Relations
  • Multimedia
  • Political Action Committee
• Newsroom
  • News Releases
  • Annual Reports
  • APA Member and DB/SA Resources
  • APA Daily Bulletin
• Members Corner

• Home
• Research
• DSM
• DSM-V
• Meet the Task Force
• Fawcett

Jan Fawcett, M.D.

Name, Degree:  Jan Fawcett, M.D.
Role(s) in Task Force and Work Group: Chair, Mood Disorders Work Group
Institutional Affiliation(s):  University of New Mexico School of Medicine
City, State:  Albuquerque, NM

Dr. Jan Fawcett, a graduate of Yale University School of Medicine, joined the Department of Psychiatry of the University of New Mexico School of Medicine, after thirty years of service as the Stanley Harris, Sr. Chairman of the Department of Psychiatry at Rush Medical College in Chicago. He has pursued a career of research in the treatment of affective disorders and the prevention of suicide since completing his fellowship at the National Institute of Mental Health Clinical Center in 1964. Dr Fawcett has been awarded the Dr. Jan Fawcett Humanitarian Award by the National Depressive and Manic Depressive Association (now the Depression and Bipolar Support Alliance), and lifetime research awards by the American Association of Suicidology and the American Foundation for Suicide Prevention. He was also presented the Menninger award by the American College of Physicians for his research in mental health in 2000. More recently in 2005, Dr Fawcett shared the Falcone Prize for affective disorders research from the National Alliance for Research in Schizophrenia and Depression (NARSAD). He is currently a principal investigator of the “Recurrent Depression Prevention with Medication and Cognitive Behavioral Therapy” project, a five year study funded by NIMH at Rush Medical Center in collaboration with investigators at Vanderbilt and the University of Pennsylvania. He is a co-author of the APA Practice Guidelines on the assessment and management of suicidal patients and is the chairperson of the DSM-V Mood Disorders Work Group from 2007-2012. Dr. Fawcett has always maintained an active clinical practice focusing on patients with treatment resistant major affective disorders and continues to do so in his work as a Professor at the University of New Mexico School of Medicine, Department of Psychiatry.

Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V :   Three calendar years before  nomination and Each year thereafter through the present calendar year.  (For 2008, activities to date and commitments for remainder of year.)

The two tables below represent Dr. Fawcett’s disclosure of significant interests and affiliations for:  (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present. 

Dr. Fawcett has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.

Disclosure of significant interests including:  Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force

Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on  the DSM-V Task Force, to the present.  (For 2008, activities to date and commitments for remainder of year.)